230 related articles for article (PubMed ID: 27350630)
1. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.
Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q
Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
[TBL] [Abstract][Full Text] [Related]
3. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D
J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422
[TBL] [Abstract][Full Text] [Related]
4. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs.
Chemnitz JM; Lanfranco AR; Braunstein I; Riley JL
J Immunol; 2006 Jun; 176(11):6603-14. PubMed ID: 16709818
[TBL] [Abstract][Full Text] [Related]
5. The influence of cyclosporin A on lymphocyte attenuator expression.
Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
[TBL] [Abstract][Full Text] [Related]
6. [miR-126 knockdown enhances the activity of murine CD4+ T cells in vivo and promotes their differentiation into Th1 cells].
Cui P; Hu Y; Tao Y; Chen C; Zhao J; Guo M; Zhou Y; Xu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):347-51. PubMed ID: 26927555
[TBL] [Abstract][Full Text] [Related]
7. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.
Otsuki N; Kamimura Y; Hashiguchi M; Azuma M
Biochem Biophys Res Commun; 2006 Jun; 344(4):1121-7. PubMed ID: 16643847
[TBL] [Abstract][Full Text] [Related]
9. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
[TBL] [Abstract][Full Text] [Related]
11. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-126 Deficiency Affects the Development of Thymus CD4+ Single-Positive Cells through Elevating IRS-1.
Hu L; Xu H; Lu J; Zhou Y; Chu F; Zheng W; Lei L; Zhao J; Wang H; Guo M; Chen C; Xu L
Int Arch Allergy Immunol; 2018; 177(3):207-218. PubMed ID: 30048989
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
14. miR-20a inhibits TCR-mediated signaling and cytokine production in human naïve CD4+ T cells.
Reddycherla AV; Meinert I; Reinhold A; Reinhold D; Schraven B; Simeoni L
PLoS One; 2015; 10(4):e0125311. PubMed ID: 25884400
[TBL] [Abstract][Full Text] [Related]
15. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
16. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells.
Krieg C; Han P; Stone R; Goularte OD; Kaye J
J Immunol; 2005 Nov; 175(10):6420-7. PubMed ID: 16272294
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
[TBL] [Abstract][Full Text] [Related]
19. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
20. BTLA associates with increased Foxp3 expression in CD4(+) T cells in dextran sulfate sodium-induced colitis.
Zhang HX; Zhu B; Fu XX; Zeng JC; Zhang JA; Wang WD; Kong B; Xiang WY; Zhong J; Wang CY; Zheng XB; Xu JF
Int J Clin Exp Pathol; 2015; 8(2):1259-69. PubMed ID: 25973010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
